Search Results
Jul 23, 2026, 08:56 ET Synaptiq Therapeutics Launches with Acquisition of Clinical-Stage SYN-001 Program
https://www.cdc.gov/nchs/data/vsrr/vsrr043.pdf Bassett AS, Chow E, Husted W, et al. J Med Genet. 2009;46(5):324-330. doi:10.1136/jmg.2008.063800 Blagojevic C, Heung T, Theriault M, et al. CMAJ Open. 2021;9(3):E802-E809. doi:10.9778/cmajo.20200294
More news about: Synaptiq Therapeutics
Jul 23, 2026, 08:51 ET Synaptiq Therapeutics Launches with Acquisition of Clinical-Stage SYN-001 Program
https://www.cdc.gov/nchs/data/vsrr/vsrr043.pdf Bassett AS, Chow E, Husted W, et al. J Med Genet. 2009;46(5):324-330. doi:10.1136/jmg.2008.063800 Blagojevic C, Heung T, Theriault M, et al. CMAJ Open. 2021;9(3):E802-E809. doi:10.9778/cmajo.20200294
More news about: Synaptiq Therapeutics
Jul 23, 2026, 03:33 ET Lundbeck receives FDA Fast Track designation for Lu AH69593, an investigational orexin 2 receptor agonist for narcolepsy
LinkedIn.References: Scammell TE. Narcolepsy. N Engl J Med. 2015;373:2654–2662.Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet. 2007;369:499–511. Bassetti CLA,
More news about: H. Lundbeck A/S
Jul 23, 2026, 03:29 ET Lundbeck receives FDA Fast Track designation for Lu AH69593, an investigational orexin 2 receptor agonist for narcolepsy
LinkedIn.References: Scammell TE. Narcolepsy. N Engl J Med. 2015;373:2654–2662.Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet. 2007;369:499–511. Bassetti CLA,
More news about: H. Lundbeck A/S
Jul 23, 2026, 02:08 ET Haisco's Class 1 Innovative Drug Ciprocopan Succinate Tablets Approved in China, Offering a New Treatment Option for Patients With PNH
of Hematology, 2024, 45(8): 727-737. Hillmen P, Lewis SM, Bessler M, et al. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med, 1995, 333(19): 1253-1258.Dingli D. Improved therapy for paroxysmal nocturnal hemoglobinuria. Ann Blood. 2026;11:8. doi:10.21037/aob-2025-1-62Xu
More news about: Haisco Pharmaceutical Group Co., Ltd.
Jul 22, 2026, 11:20 ET Economic Analysis of the Chemo Mouthpiece® Medical Device Suggests Potential Cost Savings of Over $15,000 per Patient Receiving Chemotherapy and Reduced Healthcare Resource Utilization
accessible through prior authorization and medical exception pathways, consistent with standard new-to-market product coverage protocols. While formal med-tech committee reviews and contracting negotiations are ongoing, Chemomouthpiece, LLC continues to make progress toward expanded access and long-term
More news about: Chemomouthpiece, LLC
Jul 22, 2026, 09:00 ET HOYA Vision Care North America to Share Heritage and Commitment to Eye Care Professionals Through Educational Sensei Innovation™ Events
hoyavision.com.About HOYA CorporationFounded in 1941 in Tokyo, Japan, HOYA is a global technology and med-tech company, and a leading supplier of innovative high-tech and medical products. HOYA is active in the fields of healthcare and information technology,
More news about: HOYA Vision Care, North America
Jul 22, 2026, 06:50 ET Neurimmune sells a portion of its royalty interest in cliramitug to Royalty Pharma
Partners acted as financial advisor, Mintz and Schellenberg Wittmer as legal advisors to Neurimmune.1 Garcia-Pavia et al., N Engl J Med 2023; 389(3):239.2 Kahr et al., Nature Medicine 2026; in press.3 Michalon et al., Nat Commun 2021;
More news about: Neurimmune
Jul 21, 2026, 11:03 ET Velo Med Spa Introduces Velo BreastLyft™, a Non-Surgical Approach to Breast Enhancement
results designed to enhance - not redefine - their appearance.To learn more or schedule a consultation, contact Velo Med Spa.About Velo Med SpaVelo Med Spa is an aesthetics practice in Jensen Beach, Florida, offering advanced injectable, regenerative and skin-rejuvenation treatments.
More news about: Velo Med Spa
Jul 21, 2026, 10:15 ET Prezent Vivo 1.0 accelerates AI-native med comms with AI-generated posters and fixed-price scientific delivery
multimedia:https://www.prnewswire.com/news-releases/prezent-vivo-1-0-accelerates-ai-native-med-comms-with-ai-generated-posters-and-fixed-price-scientific-delivery-302830965.htmlSOURCE
More news about: Prezent
Jul 21, 2026, 08:41 ET New Research of 861 Marketing and PR Professionals Reveals Nearly Half of Podcast Marketers Claim Strong ROI, But Measurement Hasn't Caught Up
Results are reported in aggregate.About Outcomes Rocket: Outcomes Rocket is a leading healthcare marketing agency that helps health tech, med tech, and healthcare organizations accelerate growth and achieve measurable results. Founded by Saul Marquez, the firm combines healthcare expertise
More news about: Outcomes Rocket
Jul 21, 2026, 07:14 ET The Art of Happiness: Cuộc thi hội họa toàn quốc tôn vinh sức sáng tạo của thế hệ trẻ Việt Nam
Lotus Gallery, cùng sự đồng hành của Club Med và SERENE, The Art of Happiness là cuộc thi hội họa toàn quốc dành cho thanh thiếu niên, mang đến một không gian sáng tạo để các em nhỏ tự do khám
More news about: The Brand Promise
Jul 21, 2026, 07:00 ET Alebund Pharmaceuticals Announces First Participant Randomized and Dosed in Global Phase IIb Multi-Regional Clinical Trial of AP306 for Hyperphosphatemia
2008;52(3):519–530.[4] CIC, Global and Chinese Hyperphosphatemia Drug Industry Blue Book, 2023.[5] Guedes M, et al. Kidney Med. 2023;5(2):100584. doi:10.1016/j.xkme.2022.100584.[6] Prospectus of Alebund Pharmaceuticals (Jiangsu) Limited dated June 18, 2026[7]
More news about: Alebund Pharmaceuticals
Jul 20, 2026, 08:03 ET VIO Med Spa Unveils Next-Generation Store Design as New National Brand Standard
VIO Med Spa locations will be built using the new prototype, while existing franchise owners will have the opportunity to incorporate elements of the redesign through optional retrofit packages ranging from cosmetic enhancements to more comprehensive renovations.To learn more about VIO Med Spa's
More news about: VIO Med Spa
Jul 17, 2026, 07:00 ET DIMERIX EXPANDS PIPELINE WITH ACQUISITION OF PHASE 2 READY ASSET FOR ACUTE KIDNEY INJURY
represents a promising and innovative approach to addressing a major clinical challenge for patients undergoing cardiac surgery."Univ.-Prof. Dr. med. Alexander Zarbock, Chair and Director of the Department of Anesthesiology, Intensive Care Medicine and Pain Therapy at the University Hospital Münster,
More news about: Dimerix Limited
Jul 17, 2026, 01:25 ET Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA
SmPC Oczyesa®Giustina A., et al. Acromegaly. N Engl J Med. 2025 Nov 13;393(19):1926-1939.Webb SM, et al. Quality of Life in Acromegaly. Neuroendocrinology. 2016;103(1):106-111.Crisafulli
More news about: Camurus AB
Jul 17, 2026, 01:22 ET Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA
SmPC Oczyesa®Giustina A., et al. Acromegaly. N Engl J Med. 2025 Nov 13;393(19):1926-1939.Webb SM, et al. Quality of Life in Acromegaly. Neuroendocrinology. 2016;103(1):106-111.Crisafulli
More news about: Camurus AB
Jul 16, 2026, 10:09 ET BIOTRONIK Neuro erwirbt Rückenmarkstimulationssystem von Soin Neuroscience
Juli 2026 /PRNewswire/ -- Soin Neuroscience, ein in Dayton, Ohio, ansässiges innovatives Medizintechnikunternehmen, das vom Schmerzmediziner Dr. med. Amol Soin gegründet wurde, gab heute den Verkauf eines Portfolios an geistigem Eigentum im Bereich der Rückenmarkstimulation (Spinal Cord Stimulation,
More news about: Soin Neuroscience
Jul 16, 2026, 09:40 ET Saluda Medical Announces First U.S. Surgical Cases Using Newly Approved CAP24™ Paddle Lead
closed-loop vs open-loop SCS for the treatment of chronic pain: 36-month results of the EVOKE blinded randomized clinical trial. Reg Anesthesia Pain Med 2023;0:1-9.
More news about: Saluda Medical
Jul 15, 2026, 13:21 ET International Luxury Hotel Association's INSPIRE 2026 Returns to Orlando This December
Tina Edmundson, President of Luxury at Marriott International, and Carolyne Doyon, President & CEO of Club Med North America & Caribbean, Confirmed as Headline SpeakersPALM BEACH, Fla., July 15,
More news about: International Luxury Hotel Association
Jul 15, 2026, 11:50 ET Allt eftersom elfordon blir allt vanligare, hur VinFast och Green SM skapar ett bättre transportsystem
decennium åt att påskynda omställningen till elektrisk mobilitet. I dag är elbilar på väg att bli en del av vardagen över hela kontinenten. Men i takt med att elektrifieringen rör sig från ambition till verklighet väcks en ny fråga. Hur kan Europa bygga ett transportsystem som inte bara är renare, utan
More news about: VinFast
Jul 15, 2026, 11:32 ET Efterhånden som elbiler bliver mere almindelige, hvordan VinFast og Green SM skaber et bedre transportsystem
sig. Den første udfordring var at erstatte forbrændingsmotorer med nulmissionsalternativer. Den næste udfordring er mere kompleks. Den handler om at skabe et transportsystem, der er mere effektivt, mere tilgængeligt og bedre forbundet med folks hverdag.Dette skifte afspejles i Europa-Kommissionens
More news about: VinFast
Jul 15, 2026, 08:45 ET Outcomes Matter Innovations Names Healthcare Entrepreneur Joseph H. Davi as Board Observer
innovative solutions that improve outcomes and make care more affordable for patients, providers, and payors."Davi is the founder and CEO of Med-Metrix, a privately held healthcare technology and outsourcing company serving healthcare providers nationwide. Since founding the company in 2011, he
More news about: Outcomes Matter Innovations, LLC
Jul 15, 2026, 07:00 ET Shapiro+Raj Promotes Lisa La Brooy to President as Firm Accelerates Category-Outpacing Growth
as Shapiro+Raj continues to significantly outpace growth in the broader insights category, deepen its partnerships with leading pharma, biotech, and med devices companies, and scale its differentiated human-led, AI-amplified model.La Brooy brings more than 20 years of experience in client-facing
More news about: SHAPIRO+RAJ
Jul 14, 2026, 10:35 ET Cision lägger till AI Search Visibility till CisionOne, och hjälper PR-team att spåra hur varumärken visas i AI-svar
röstandel med konkurrenterFörstå känslan förknippad med deras varumärke i AI-genererade svarIdentifiera de frågor och ämnen där deras varumärke visasSe vilka journalister, publikationer och domäner som citeras i AI-genererade svarKoppla samman AI-synlighet med medieövervakning,
More news about: Cision Ltd.